The Market for Mass Spectrometry in Clinical Testing Applications

Jan 3, 2017
208 Pages - Pub ID: KLI15217025
Share this report
 
Online Download $4,500
Departmental Site License (one location, 10 users) $6,750
Global Site License $9,000
What is the Market for Mass Spectrometry in Clinical Testing Applications? 

According to Kalorama Information, the market for mass spectrometry is 1.5 billion dollars.   While the lion's share of the market is research-based, a growing portion of the mass spectrometry industry is for clinical applications.  Kalorama Information's report segments these application markets, and details important developments in the industry.  

Mass spectrometry has been primarily used in research applications, with early applications focused on small molecules. However, development of soft-ionization techniques such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) has made it possible to study larger molecules such as proteins, peptides, DNA, and other large molecules without extensive fragmentation, opening up a whole new world of opportunities as mass spectrometry now moves into the clinical laboratory. The Market for Mass Spectrometry in Clinical Testing Applications focuses on the worldwide market for mass spectrometry products – instruments and consumables – and includes the following information:

  • Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and Services Provided by Mass Spectrometry Companies] (Total mass spectrometry market; Product Revenue: Instruments, Reagents/Consumables, Total product revenue; Service revenue)
  • Mass Spectrometry Market (Products) – Research vs. Clinical, 2016 and 2021
  • Mass Spectrometry Product Market by Geographical Region, Worldwide, 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
  • Mass Spectrometry Market Share by Company, 2016 (%)
  • Clinical Mass Spectrometry Product Market by Intended Clinical Category, 2016 (%) (Microbial Identification, Small molecule applications)
  • Mass Spectrometry Market – By Type of Mass Spectrometer (%)

The report looks as well at the market drivers and challenges for mass spectrometry in the clinical lab, including the advantages and disadvantages of mass spectrometry and current trends in the mass spectrometry market. 

The clinical diagnostic applications of mass spectrometry are expanding. Mass spectrometry has already had a disruptive impact on microbial identification. Mass spectrometry is now being applied to a growing number of oncology applications, and there is a growing awareness of the importance of both genomic and proteomic information for many oncology diagnostic applications. Mass spectrometry has the potential to be applied to other diagnostic applications as well, as discussed in this report. 

With this market potential, many companies are making deals in this promising area. The report discusses selected investment and financing agreements in mass spectrometry companies, selected acquisitions, selected agreements between mass spectrometry companies, selected agreements between mass spectrometry platform/reagent companies and mass spectrometry software companies, selected company agreements between mass spectrometry companies and diagnostic companies or clinical laboratories, selected agreements among mass spectrometry companies and pharmaceutical or biopharmaceutical companies (includes contract research organizations providing services to pharma companies), and selected mass spectrometry company agreements with academic or other non-profit organizations. 

The report includes company profiles of the players in the mass spectrometry market:

  • 908 Devices Inc.
  • Abbott Laboratories
  • Advion, Inc.
  • Agena Bioscience, Inc.
  • Agilent Technologies Inc.
  • Andromas SAS
  • Applied Proteomics, Inc.
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • BGI
  • Biocrates Life Sciences AG
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Caprion Biosciences, Inc.
  • caprotec bioanalytics GmbH
  • Danaher Corporation
  • Fluidigm Corporation
  • ImaBiotech
  • Integrated Diagnostics, Inc.
  • JEOL Ltd.
  • KineMed, Inc.
  • Microsaic Systems plc
  • mosaiques diagnostics and therapeutics AG and DiaPat GmbH
  • PerkinElmer, Inc.
  • Proteome Sciences plc
  • SCIEX
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
    Chapter 1: Executive Summary
    Overview
    Scope and Methodology
    Market Overview
    Future Prospects in the Mass Spectrometry Market

    Chapter 2: Introduction
    Brief History of Mass Spectrometry
    Point-of-View
    Research Applications
    Clinical Applications

    Chapter 3: Mass Spectrometry Overview
    Types of Mass Spectrometry – Overview
    Companies Marketing Mass Spectrometry Platforms and Related Products
    Mass Spectrometry Platforms in the Clinical Laboratory

    Chapter 4: Mass Spectrometry in Research and the Clinical Laboratory
    Research Applications of Mass Spectrometry
    Mass Spectrometry in the Clinical Laboratory
    Early Applications of Mass Spectrometry in the Clinical Laboratory
    Oncology
    Infectious Disease
    Other Clinical Applications of Mass Spectrometry
    Other Applications of Mass Spectrometry

    Chapter 5: Deals – Mass Spectrometry Companies
    Investments and Financing Agreements
    Mergers and Acquisitions
    Other Corporate Agreements and Collaborations
    Collaborations/Agreements Between Two Mass Spectrometry Companies
    Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
    Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
    Other Company Collaborations/Agreements
    Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government

    Chapter 6: Mass Spectrometry in the Clinical Laboratory – Market Drivers and Challenges
    Mass Spectrometry Technology and Platforms
    Need for Integration of Pre-analytical, Analytical, and Post-analytical Components of Mass Spectrometry Based Assays; Advances in Mass Spectrometry Platforms
    Mass Spectrometry vs. Immunoassays – Advantages and Disadvantages
    Mass Spectrometry Clinical Market Drivers
    Increasing Number of Clinical Applications for Mass Spectrometry
    Oncology Market Drivers
    Newborn Screening and Genetic Analysis Market Drivers
    Infectious Disease Market Drivers
    Market Drivers for Other Segments of the Clinical Mass Spectrometry Market
    Competition
    Potential Impact of Mass Spectrometry on Other Markets
    Most Mass Spectrometry Clinical Assays Today are Laboratory Developed Tests (LDTs)
    Regulation of Mass Spectrometry-Based In Vitro Diagnostic (IVD) Tests
    Future Prospects

    Chapter 7: Mass Spectrometry Market Analysis
    Mass Spectrometry Market Overview
    Research versus Clinical Mass Spectrometry Market
    Mass Spectrometry Market – Geographical Distribution
    Mass Spectrometry Market – Market Shares by Company
    Mass Spectrometry Market (Products Sold to Clinical Laboratories) – By Intended Clinical Category, 2016
    Mass Spectrometry Market – By Type of Mass Spectrometer

    Chapter 8: Company Profiles – Mass Spectrometry Companies
    908 Devices Inc.
    Abbott Laboratories
       Recent Revenue History
       Company Overview – With a Focus on Sequencing
    Advion, Inc.
    Agena Bioscience, Inc.
       Applying MassARRAY System to Clinical Diagnostics
    Agilent Technologies Inc.
       Recent Revenue History
       Company Overview
    Andromas SAS
    Applied Proteomics, Inc.
    Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
       Revenue History
       Company Overview
    BGI
    Biocrates Life Sciences AG
    Biodesix, Inc.
    Biodesix Lung Reflex™
       Research Activities
       Investors/Financings
       Other Agreements
    Biognosys AG
    bioMérieux SA
       Recent Revenue History
       Company Overview
       Traditional Microbiology
       Mass Spectrometry for Clinical Laboratories
    Bio-Rad Laboratories, Inc.
       Recent Revenue History
       Company Overview
    Bruker Corporation
       Recent Revenue History
       Company Overview
    Caprion Biosciences, Inc.
    caprotec bioanalytics GmbH
    Danaher Corporation
       Recent Revenue History
       Company Overview
    Fluidigm Corporation
       Recent Revenue History
       Company Overview
    ImaBiotech
    Integrated Diagnostics, Inc.
       Financing History
       Selected Deals
    Indi Molecular
    JEOL Ltd.
       Recent Revenue History
       Company Overview
    KineMed, Inc.
    Microsaic Systems plc
       Recent Revenue History
       Company Overview
    mosaiques diagnostics and therapeutics AG and DiaPat GmbH
    PerkinElmer, Inc.
       Recent Revenue History
       Company Overview
    Proteome Sciences plc 
       Recent Revenue History
       Company Overview
    SCIEX
    Sera Prognostics, Inc.
    Shimadzu Corporation
       Recent Revenue History
       Company Overview
    Thermo Fisher Scientific, Inc.
       Recent Revenue History
       Company Overview
    Waters Corporation
       Recent Revenue History
       Company Overview


    L I S T   O F   E X H I B I T S

    1: Executive Summary
    Table 1-1: Worldwide Mass Spectrometry Product Revenues (Instruments and
    Consumables), 2016 and 2021

    3: Mass Spectrometry Overview

    Table 3-1: Selected Companies Developing/Marketing Mass Spectrometers
    Table 3-2: Selected Companies Marketing Tools/Reagents/Kits/Consumables
    for Mass Spectrometry
    Table 3-3: Selected Companies Marketing Software for Mass Spectrometry
    Table 3-4: Selected Companies Marketing Mass Spectrometers and/or Assays for the
    Clinical Laboratory [CE-Marked and/or 510(k) cleared]

    4: Mass Spectrometry in Research and the Clinical Laboratory

    Table 4-1: Selected Mass Spectrometry Based Oncology Tests
    Table 4-2: Selected Mass Spectrometry Based Infectious Disease Tests for
    Microorganism Identification and Antibiotic Susceptibility
    Table 4-3: Selected Other Mass Spectrometry Based Clinical Tests

    5: Deals – Mass Spectrometry Companies

    Table 5-1: Selected Investment and Financing Agreements in Mass Spectrometry
    Companies
    Table 5-2: Selected Acquisitions of Mass Spectrometry Companies
    Table 5-3: Selected Company Agreements Between Two Mass Spectrometry
    Companies
    Table 5-4: Selected Company Agreements Between Mass Spectrometry Platform/
    Reagent Companies and Mass Spectrometry Software Companies
    Table 5-5: Selected Company Agreements Between Mass Spectrometry Companies
    and Diagnostic Companies or Clinical Laboratory
    Table 5-6: Selected Agreements Mass Spectrometry Companies and Pharmaceutical
    or Biopharmaceutical Companies [Includes Contract Research Organizations
    Providing Services to Pharma Companies]
    Table 5-7: Selected Other Mass Spectrometry Company Agreements
    Table 5-8: Selected Mass Spectrometry Company Agreements with Academic or
    Other Non-Profit Organizations

    6: Mass Spectrometry in the Clinical Laboratory – Market Drivers and
    Challenges
    Table 6-1: Advantages and Disadvantages of Mass Spectrometry
    Table 6-2: Trends in the Mass Spectrometry Market

    7: Mass Spectrometry Market Analysis

    Table 7-1: Mass Spectrometry Market, Worldwide, 2016 and 2021 [Products and
    Services Provided by Mass Spectrometry Companies] (Total mass spectrometry
    market; Product Revenue: Instruments, Reagents/Consumables, Total product
    revenue; Service revenue)
    Table 7-2: Mass Spectrometry Market (Products) – Research vs. Clinical, 2016
    and 2021
    Table 7-3: Mass Spectrometry Product Market by Geographical Region, Worldwide,
    2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market)
    Table 7-4: Mass Spectrometry Market Share by Company, 2016 (%)
    Table 7-5: Clinical Mass Spectrometry Product Market by Intended Clinical
    Category, 2016 (%) (Microbial Identification, Small molecule applications)
    Table 7-6: Mass Spectrometry Market – By Type of Mass Spectrometer (%)

    8: Company Profiles – Mass Spectrometry Companies

    Table 8-1: Abbott Revenues (2013, 2014, 2015, 3 quarters of 2016)
    Table 8-2: Agilent Technologies Revenues (2013, 2014, 2015)
    Table 8-3: bioMérieux Revenues (2013, 2014, 2015, 3 quarters of 2016)
    Table 8-4: Bio-Rad Laboratories Revenues (2013, 2014, 2015, 3 quarters of
    2016)
    Table 8-5: Bruker Corporation Revenues (2013, 2014, 2015, 3 quarters of 2016)
    Table 8-6: Danaher Revenues (2013, 2014, 2015, 3 quarters of 2016)
    Table 8-7: Fluidigm Revenues (2013, 2014, 2015, 3 quarters of 2016)
    Table 8-8: Microsaic Systems Revenues (2013, 2014, 2015)
    Table 8-9: PerkinElmer Revenues (2015 and 2016)
    Table 8-10: Proteome Sciences Revenues (2013, 2014, 2015)
    Table 8-11: Shimadzu Revenues (Years Ending March 31, 2016 and 2015)
    Table 8-12: Thermo Fisher Scientific Revenues (2013, 2014, 2015)
    Table 8-13: Waters Corporation Revenues (2013, 2014, 2015)

    In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

    We were unable to search inside this report.

    Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

    Please note that your term must be at least three characters long and numbers will be blocked by the # sign.